Form 4: Forrester Research Executive Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Carrie Johnson, Chief Product Officer at Forrester Research, reports the vesting of restricted stock units and subsequent tax withholding.

Summary

  • Carrie Johnson, Chief Product Officer of Forrester Research, filed a Form 4 detailing changes in beneficial ownership.
  • On April 1, 2025, 6,001 restricted stock units vested and converted into common stock.
  • The company withheld 2,241 shares to cover tax obligations at a price of $9.36 per share.
  • Johnson was granted 33,333 new restricted stock units on April 1, 2025, vesting in equal installments over four years.
  • Additionally, Johnson was granted 66,666 non-qualified stock options exercisable in four equal installments beginning April 1, 2026, expiring March 31, 2035, with an exercise price of $9.36.
  • Following these transactions, Johnson directly owns 24,973 shares of common stock, 18,002 restricted stock units from a previous grant, 33,333 restricted stock units from the new grant, and 66,666 non-qualified stock options.

Sentiment

Score: 7

Explanation: The document itself is neutral, simply reporting transactions. The granting of stock options and restricted stock units is generally a positive sign, indicating confidence in the company's future, but it's a routine filing.

Positives

  • The vesting of restricted stock units and granting of new units and options suggests continued alignment of the executive's interests with the company's performance.
  • The executive's continued holding of a significant number of shares, restricted stock units, and options indicates confidence in the company's future prospects.

Future Outlook

The document does not contain specific forward-looking statements about the company's overall financial performance or strategic direction, but the granting of stock options and restricted stock units suggests an expectation of future value creation.

Industry Context

Executive compensation through stock options and restricted stock units is a common practice in the research and advisory industry to incentivize performance and align management interests with shareholders. The specific terms of these grants are typical for executive compensation packages.

Comparison to Industry Standards

  • Stock option and RSU grants are standard practice for publicly traded companies like Forrester Research.
  • Comparable companies such as Gartner, Inc. and The Hackett Group also utilize similar equity-based compensation plans to attract and retain key executives.
  • The vesting schedules and exercise prices are generally in line with industry norms for executive compensation packages.

Stakeholder Impact

  • Shareholders may view the vesting of restricted stock units and granting of new options as a sign of continued alignment between management and shareholder interests.
  • Employees may see this as a positive sign of the company's commitment to its executives.

Key Dates

DateDescription
04/01/2024Reporting person was granted 24,003 Restricted Stock Units that vest and convert into common stock in four equal and consecutive installments beginning on the first anniversary of the grant date.
04/01/2025Earliest transaction date; 6,001 restricted stock units vested and converted into common stock; 2,241 shares withheld for taxes; 33,333 new restricted stock units granted; 66,666 non-qualified stock options granted.
04/03/2025Date of Form 4 filing.
03/31/2035Expiration date of the non-qualified stock options.

Keywords

Form 4, beneficial ownership, restricted stock units, stock options, Forrester Research, Johnson Carrie, executive compensation, insider trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.